Search research articles
Contact Us
Filters
Showing results (411-420 of 512) with videos related to
Page
of 52
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort
Simon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Translational Lung Cancer Research
|
May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
Victoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Lizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2020
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial
Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, et al.
Lung Cancer (Auckland, N.Z.)
|
June 28, 2024
Top 20 <i>EGFR+</i> NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating <i>EGFR</i> Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey
Sai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 30, 2026
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
Hidetoshi Hayashi, Byoung Chul Cho, David R Spigel, et al.
NPJ Precision Oncology
|
February 26, 2024
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
Page
of 52
Search research articles
Search
Showing results (411-420 of 512) with videos related to
Sort By:
Page
of 52
European Journal of Cancer (Oxford, England : 1990)
|
March 12, 2022
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort
Simon Baldacci, Benjamin Besse, Virginie Avrillon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 5, 2020
Circulating T-cell Immunosenescence in Patients with Advanced Non-small Cell Lung Cancer Treated with Single-agent PD-1/PD-L1 Inhibitors or Platinum-based Chemotherapy
Roberto Ferrara, Marie Naigeon, Edouard Auclin, et al.
Translational Lung Cancer Research
|
May 20, 2021
EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer
Victoria Foy, Colin R Lindsay, Alexandra Carmel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 5, 2021
Intracranial Efficacy of Selpercatinib in <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancers on the LIBRETTO-001 Trial
Vivek Subbiah, Justin F Gainor, Geoffrey R Oxnard, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 20, 2019
Outcome of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with Checkpoint Inhibitors
Lizza E L Hendriks, Clemence Henon, Edouard Auclin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
July 19, 2018
Frequency of Brain Metastases and Multikinase Inhibitor Outcomes in Patients With RET-Rearranged Lung Cancers
Alexander Drilon, Jessica J Lin, Thomas Filleron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 8, 2020
Randomized Phase II Trial Evaluating Treatment with EGFR-TKI Associated with Antiestrogen in Women with Nonsquamous Advanced-Stage NSCLC: IFCT-1003 LADIE Trial
Julien Mazieres, Fabrice Barlesi, Isabelle Rouquette, et al.
Lung Cancer (Auckland, N.Z.)
|
June 28, 2024
Top 20 <i>EGFR+</i> NSCLC Clinical and Translational Science Papers That Shaped the 20 Years Since the Discovery of Activating <i>EGFR</i> Mutations in NSCLC. An Editor-in-Chief Expert Panel Consensus Survey
Sai-Hong Ignatius Ou, Xiuning Le, Misako Nagasaka, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 30, 2026
Long-Term Impact of First-Line Amivantamab Plus Lazertinib Versus Osimertinib on Mechanisms of Acquired Resistance in MARIPOSA: A Brief Report
Hidetoshi Hayashi, Byoung Chul Cho, David R Spigel, et al.
NPJ Precision Oncology
|
February 26, 2024
Genomic landscape of liquid biopsy mutations in TP53 and DNA damage genes in cancer patients
Damien Vasseur, Ahmadreza Arbab, Fabiola Giudici, et al.
Page
of 52